duloxetine 30 mg
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules, USP are indicated for the treatment of: • Major Depressive disorder in adults • Generalized Anxiety disorder in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain in adults • Fibromyalgia in adults and pediatric patients 13 years of age and older • Chronic Musculoskeletal Pain in adults Duloxetine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: • Major Depressive disorder (MDD) in adults ( 1 ) • Generalized Anxiety Disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 ) • Diabetic Peripheral Neuropathic Pain (DPNP) in adults ( 1 ) • Fibromyalgia (FM) in adults and pediatric patients 13 years of age and older ( 1 ) • Chronic Musculoskeletal Pain in adult ( 1 )
Solco Healthcare US, LLC
CAPSULE GREEN 558 30MG
Related Pills
duloxetine 60 mg
Solco Healthcare US, LLC
duloxetine 20 mg
Solco Healthcare US, LLC
duloxetine 30 mg
solco healthcare us, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
DULOXETINE delayed-release capsules, USP are available as delayed release capsules in the following strengths, colors, imprints, and presentations: Features Strengths 20 mg a 30 mg a 60 mg a Body color Opaque white Opaque light green Opaque dark blue Cap color Opaque white Opaque white Opaque white Cap imprint 557 558 559 Body imprint 20mg 30mg 60mg capsule number Coni-Snap Coni-Snap Coni-Snap Presentations and NDC Codes Bottles of 30 43547-379-03 43547-380-03 43547-381-03 Bottles of 60 43547-379-06 - - Bottles of 90 43547-379-09 43547-380-09 43547-381-09 Bottles of 1000 43547-379-11 43547-380-11 43547-381-11 a equivalent to
DULOXETINE base 16.2 Storage and Handling Store at 20 o C to 25 o C (68 o F to 77 o F); excursions permitted between 15 o C to 30 o C (59 o F to 86 o F) [See USP Controlled Room Temperature].
More pills like CAPSULE 558 30MG